Q2 2019 Report: Global Trends in Biopharma Transactions

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q2 2019 Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life science deal...

Q2 2019: Global Trends in Medtech Transactions

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q2 2019 Report: Global Trends in Medtech Transactions applies the latest data to analyze current activities in the life sciences deal...

Q1 2019: Global Trends in Medtech Transactions

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q1 2019 Report: Global Trends in Medtech Transactions applies the latest data to analyze current activities in the life sciences deal...

Q1 2019 Report: Global Trends in Biopharma Transactions

In this report you can find an overview and analysis of the following across the biopharma market in the US, Europe, and Asia (China and Japan). Key performance indicators for the life science market​​ IPO and private financing activity and performance​​ Deal activity...

2018 Annual Trends in Medtech Transactions Report

Locust Walk is a global life sciences transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...

2018 Annual Trends in Biopharma Transactions Report

Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...